VTD-melphalan is well tolerated and results in very high...

OncoTargets and Therapy 2017 / 01 Vol. Volume 10

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Nadiminti, Kalyan, Abbi, Kamal Kant Singh, Mott, Sarah, Dozeman, Lindsay, Tricot, Annick, Schultz, Allyson, Behrends, Sonya, Zhan, Fenghuang, Tricot, Guido
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 10
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S112423
Date:
January, 2017
File:
PDF, 547 KB
english, 2017
Conversion to is in progress
Conversion to is failed